Vijaya Diagnostic Centre announced a robust performance for Q3 FY2026, achieving a 21.4% Year-over-Year (YoY) revenue growth for the quarter, reaching Rs. 2,052.1 Mn. The nine-month (9MFY26) revenue growth stood at 17.1%. Key operational highlights include significant volume increases, with Total Tests up 14.7%, and the successful commissioning of four new hub centres in West Bengal and core markets.
Q3 FY2026 Financial Performance Highlights
Vijaya Diagnostic Centre Limited declared its consolidated financial results for the quarter and nine months ended December 31, 2025. The company demonstrated strong top-line momentum, reporting Revenue from Operations of Rs. 2,052.1 Million (Mn) in Q3 FY26, marking a 21.4% YoY increase over Q3 FY25’s Rs. 1,689.8 Mn.
Profitability metrics also showed significant improvement:
- EBITDA for the quarter grew by 28.2% to Rs. 860.5 Mn.
- EBITDA Margin expanded by 221 basis points (bps) to 41.9%.
- Profit After Tax (PAT) rose by 22.3% to Rs. 431.8 Mn.
For the nine months ended (9MFY26), total revenue reached Rs. 5,948.3 Mn (up 17.1% YoY), with PAT reaching Rs. 1,250.5 Mn (up 14.8% YoY).
Operational Milestones and Network Expansion
The growth was supported by strong underlying operational metrics, reflecting increased patient volume and better realization rates.
Operational Highlights for Q3 FY26 compared to Q3 FY25:
- Total Tests increased by 14.7% to 4.22 million.
- Total Footfall saw an 11.8% rise to 1.17 million.
- Average realization per test improved by 5.9% to Rs. 487.
Ms. Suprita Reddy, MD & CEO, commented on the results, noting the robust revenue growth of ~21.4%, supported by volume growth of nearly ~15%. She emphasized that revenues surpassed Q2 levels despite the traditional seasonal softness impacting Q3.
Strategic Growth and New Centres
During the quarter, the company aggressively expanded its network footprint, particularly in West Bengal. Four new hub centres were commissioned: two in West Bengal (Phoolbagan and Diamond Harbour) and two in core markets (Khammam and Nandyal).
A significant achievement shared was the early break-even status of the two centres launched in Q1 FY26 in West Bengal (Krishnanagar and Barasat), achieving this milestone within three quarters, well ahead of the projected one-year timeline.
Future Focus Areas
Looking ahead, the company stated its key focus areas include the stabilisation of newly launched hubs, commissioning multiple spokes across the network, and continued investment in latest technology to enhance customer experience and build brand equity in new regions.
The leadership team has also been strengthened with the addition of a CFO, CTO, and COO, alongside key hires across clinical and corporate functions to support future scaling.
Source: BSE
